NASDAQ:NOVS

Novus Capital (NOVS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$16.87
$37.64
52-Week Range
N/A
Volume
10.17 million shs
Average Volume
370,842 shs
Market Capitalization
$842,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NOVS stock logo

About Novus Capital Stock (NASDAQ:NOVS)

Novus Capital Corporation is a blank check company. The company was founded in 2020 and is based in Indianapolis, Indiana.

NOVS Stock News Headlines

The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Cary mansion sale price jumps to $9.6 million
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Novo Integrated Sciences to Get $1B in Funding
See More Headlines
Receive NOVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novus Capital and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Agricultural Production - Crops
Sub-Industry
N/A
Current Symbol
NASDAQ:NOVS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$842,000.00
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Larry M. Paulson (Age 67)
    CEO & Director
  • Mr. Vincent Donargo (Age 60)
    Chief Financial Officer

NOVS Stock Analysis - Frequently Asked Questions

What is W. Lance Anderson's approval rating as Novus Capital's CEO?

6 employees have rated Novus Capital Chief Executive Officer W. Lance Anderson on Glassdoor.com. W. Lance Anderson has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Novus Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novus Capital investors own include Verizon Communications (VZ), Utz Brands (UTZ), SPDR S&P 500 ETF Trust (SPY), NVIDIA (NVDA), GrowGeneration (GRWG) and General Electric (GE).

When did Novus Capital IPO?

Novus Capital (NOVS) raised $18 million in an initial public offering (IPO) on Wednesday, May 4th 2022. The company issued 3,800,000 shares at $4.25-$5.25 per share. EF Hutton served as the underwriter for the IPO.

This page (NASDAQ:NOVS) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners